A
Agnès Devergie
Researcher at University of Paris
Publications - 149
Citations - 11349
Agnès Devergie is an academic researcher from University of Paris. The author has contributed to research in topics: Transplantation & Bone marrow. The author has an hindex of 56, co-authored 149 publications receiving 11001 citations. Previous affiliations of Agnès Devergie include Pierre-and-Marie-Curie University & Leipzig University.
Papers
More filters
Journal ArticleDOI
Hematopoietic reconstitution in a patient with fanconi's anemia by means of umbilical-cord blood from an hla-identical sibling
Eliane Gluckman,Hal E. Broxmeyer,Arleen D. Auerbach,Henry S. Friedman,Gordon W. Douglas,Agnès Devergie,Helene Esperou,Dominique Thierry,Gérard Socié,Pierre Lehn,Scott Cooper,Denis English,Joanne Kurtzberg,Judith Bard,Edward A. Boyse +14 more
TL;DR: It is necessary to select patients suitable for vaginal or laparoscopic mesh placement for Fanconi's anemia preoperatively on the basis of prior history and once they provide informed consent for surgery.
Journal ArticleDOI
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation
Alois Gratwohl,Jo Hermans,JohnM. Goldman,William Arcese,Enric Carreras,Agnès Devergie,Francesco Frassoni,G. Gahrton,Kolb Hj,Dietger Niederwieser,Tapani Ruutu,J P Vernant,T. de Witte,Jane F. Apperley +13 more
TL;DR: In this paper, a simple system based on five main factors gives adequate risk assessment for counselling of patients and taking decisions, which is highly predictive for leukaemia-free survival, survival and transplant-related mortality.
Journal ArticleDOI
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.
Rodrigo Martino,Simona Iacobelli,Ronald Brand,Thekla Jansen,Anja van Biezen,Jürgen Finke,Andrea Bacigalupo,Dietrich W. Beelen,J Reiffers,Agnès Devergie,Emilie Alessandrino,Ghulam J. Mufti,Renee M.Y. Barge,Jorge Sierra,Tapani Ruutu,Marc Boogaerts,Michele Falda,Jean Pierre Jouet,Dieter Niederwieser,Theo de Witte +19 more
TL;DR: Patients with no contraindications for SMC should not receive RIC outside of prospective randomized trials, which are needed to establish the position of RIC-based transplantation in the treatment of patients with MDS.
Journal ArticleDOI
Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Alois Gratwohl,Ronald Brand,Jane F. Apperley,Charles Crawley,Tapani Ruutu,Paolo Corradini,Enric Carreras,Agnès Devergie,Cesare Guglielmi,H. J. Kolb,Dietger Niederwieser,Marrow Transplantation +11 more
TL;DR: Data from 592 teams in 42 European countries described their use of HSCT for CML from 1990 to 2004 to describe the current status of this option and the outcome a patient can expect today provide an objective basis for decision making.
Journal ArticleDOI
Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
ZiYi Lim,Ronald Brand,Rodrigo Martino,Anja van Biezen,Juergen Finke,Andrea Bacigalupo,Dietrich W. Beelen,Agnès Devergie,Emilio Paolo Alessandrino,Roel Willemze,Tapani Ruutu,Marc Boogaerts,Michele Falda,Jean-Pierre Jouet,Dietger Niederwieser,Nicolaus Kröger,Ghulam J. Mufti,Theo de Witte +17 more
TL;DR: Allogeneic hematopoietic stem-cell transplantation remains a potential curative therapeutic option for many older patients with MDS and disease stage at time of transplantation, but not recipient age or the intensity of the conditioning regimens, was the most important factor influencing outcomes.